Skip to main content
main-content

Zeitschrift

Annals of Surgical Oncology

Annals of Surgical Oncology 3/2017

Sonderheft 3/2017

Inhaltsverzeichnis ( 100 Artikel )

22.11.2017 | Health Services Research and Global Oncology | Sonderheft 3/2017

Letters to the Editor Anthology: An e-Supplement Resource

22.11.2017 | Health Services Research and Global Oncology | Sonderheft 3/2017

Thank You to Annals of Surgical Oncology Expert Reviewer Community

25.10.2017 | Health Services Research and Global Oncology | Sonderheft 3/2017

The Changing Face of Surgical Oncology

22.11.2017 | Health Services Research and Global Oncology | Sonderheft 3/2017

Comment on: Global Cancer Consortiums: Moving from Consensus to Practice

20.11.2017 | Health Services Research and Global Oncology | Sonderheft 3/2017

Reply: Global Cancer Consortiums: Moving from Consensus to Practice

20.11.2017 | Bone and Soft Tissue Sarcomas | Sonderheft 3/2017 Open Access

Long-Term Results of Thoraco-Pleuro-Pneumonectomy (TPP) for Recurrent Thoracic Sarcomas

20.11.2017 | Breast Oncology | Sonderheft 3/2017

Sized Influences Nodal Status in Women Aged #70 with Endocrine Responsive Breast Cancer

30.10.2017 | Breast Oncology | Sonderheft 3/2017

Using Size and Grade to Identify Women Aged ≥ 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity

Letter to Editor Reply to “Sized influences nodal status in women aged ≥ 70 with endocrine responsive breast cancer” by Fitzal, Florian et al. in Ann Surg Oncol DOI 10.1245/s10434-017-6156-0

16.10.2017 | Breast Oncology | Sonderheft 3/2017

Comment on “Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy”

16.11.2017 | Breast Oncology | Sonderheft 3/2017

Response to “Complications in DIEP Flap Breast Reconstruction after Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral and Bilateral Reconstructions”

01.12.2017 | Breast Oncology | Sonderheft 3/2017

Reply to “Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions”

28.11.2017 | Breast Oncology | Sonderheft 3/2017

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial

16.11.2017 | Breast Oncology | Sonderheft 3/2017

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial: A Reply

06.11.2017 | Breast Oncology | Sonderheft 3/2017

Vitamin D Levels Affect Breast Cancer Survival Rates

25.10.2017 | Breast Oncology | Sonderheft 3/2017

Vitamin D Levels Affect Breast Cancer Survival Rates: A Reply

30.10.2017 | Thoracic Oncology | Sonderheft 3/2017

Comments on “An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer”

30.10.2017 | Breast Oncology | Sonderheft 3/2017

Reply to An Investigation Into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products for Patients with Breast Cancer

07.11.2017 | Breast Oncology | Sonderheft 3/2017

Response to “The CUBE Technique: Continuous Ultrasound-Guided Breast Excision,” Published in August 2014 by Tummel et al. Amsterdam, 28th January 2015

16.11.2017 | Breast Oncology | Sonderheft 3/2017

Primary Locoregional Treatment in Metastatic Breast Cancer: A Reply

27.10.2017 | Breast Oncology | Sonderheft 3/2017

Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer

01.11.2017 | Breast Oncology | Sonderheft 3/2017

Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A Reply

24.10.2017 | Breast Oncology | Sonderheft 3/2017

Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-excision Rates in Breast Cancer?

06.11.2017 | Breast Oncology | Sonderheft 3/2017

Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-Excision Rates in Breast Cancer? A Reply

26.10.2017 | Breast Oncology | Sonderheft 3/2017

Comment on “Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey”

02.11.2017 | Breast Oncology | Sonderheft 3/2017

Refining Tumor Resection Techniques for Managing Inferior Pole Breast Malignancies

21.11.2017 | Breast Oncology | Sonderheft 3/2017

In Reply: Refining Tumor Resection Techniques for Managing Inferior Pole Breast Malignancies

22.11.2017 | Breast Oncology | Sonderheft 3/2017

Comment on: Sentinel Node Biopsy Using Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial

01.11.2017 | Breast Oncology | Sonderheft 3/2017

Simplifying Level 2 Oncoplastic Surgery for Lower Inner Quadrant Breast Cancers

31.10.2017 | Colorectal Cancer | Sonderheft 3/2017

Vitamin D Status May Explain Some of the Racial Disparities in Rectal Cancer

01.12.2017 | Colorectal Cancer | Sonderheft 3/2017

In Reply: Vitamin D Status May Explain Some of the Racial Disparities in Rectal Cancer

30.10.2017 | Colorectal Cancer | Sonderheft 3/2017

Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer

30.10.2017 | Colorectal Cancer | Sonderheft 3/2017

Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

13.11.2017 | Colorectal Cancer | Sonderheft 3/2017

Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older than 70 Years; Survival Benefit at Considerable Morbidity and Mortality: A Reply

30.10.2017 | Colorectal Cancer | Sonderheft 3/2017

Fancier and More Expensive Doesn’t Mean Better: An Argument for CT Staging of Patients with Colorectal Liver Metastases

22.11.2017 | Colorectal Cancer | Sonderheft 3/2017

Comment: Fancier and More Expensive Do Mean Better: An Argument for Computed Tomography Staging of Patients With Colorectal Liver Metastases

27.11.2017 | Colorectal Cancer | Sonderheft 3/2017

Comment on: Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, Not Necrosis, Predicts Outcome

30.10.2017 | Colorectal Cancer | Sonderheft 3/2017

Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients

31.10.2017 | Colorectal Cancer | Sonderheft 3/2017

Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis

30.10.2017 | Colorectal Cancer | Sonderheft 3/2017

Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply

25.10.2017 | Colorectal Cancer | Sonderheft 3/2017

The Role of Intersphincteric Resection in Very Low Rectal Cancer

03.11.2017 | Colorectal Cancer | Sonderheft 3/2017

Comment On: Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin

02.11.2017 | Colorectal Cancer | Sonderheft 3/2017

Comment on: Need for Differentiating Diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regarding Cancer Survival

20.11.2017 | Colorectal Cancer | Sonderheft 3/2017

Reply: “Adjuvant” Hyperthermic Intraperitoneal Chemotherapy: A Call to Action

16.11.2017 | Endocrine Tumors | Sonderheft 3/2017

Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States

13.11.2017 | Endocrine Tumors | Sonderheft 3/2017

Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States: A Reply

30.10.2017 | Endocrine Tumors | Sonderheft 3/2017

Comment on: Eucalcemic Parathyroid Hormone Elevation After Parathyroidectomy for Primary Sporadic Hyperparathyroidism: Risk Factors, Trend, and Outcome

22.11.2017 | Gastrointestinal Oncology | Sonderheft 3/2017

Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms

13.11.2017 | Gastrointestinal Oncology | Sonderheft 3/2017

In Reply: Centralization of Upper Gastrointestinal Cancer Care Should Be Dictated by Quality of Care

26.10.2017 | Gastrointestinal Oncology | Sonderheft 3/2017

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial

14.11.2017 | Gastrointestinal Oncology | Sonderheft 3/2017

Comment on: Open versus Minimally Invasive Resection of Gastric GIST: A Multi-institutional Analysis of Short- and Long-Term Outcomes

10.11.2017 | Gastrointestinal Oncology | Sonderheft 3/2017

Open Versus Minimally Invasive Resection of Gastric GIST: A Multi-Institutional Analysis of Short- and Long-Term Outcomes: A Reply

09.11.2017 | Gastrointestinal Oncology | Sonderheft 3/2017

Comment on: External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix

16.10.2017 | Gastrointestinal Oncology | Sonderheft 3/2017

Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers: Methodologic Issues

01.11.2017 | Gynecologic Oncology | Sonderheft 3/2017

Comment on: Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

13.10.2017 | Gynecologic Oncology | Sonderheft 3/2017

Survival Analysis in a Randomized Trial of HIPEC in Ovarian Cancer

27.10.2017 | Head and Neck Oncology | Sonderheft 3/2017

Prophylactic “First-Step” Central Neck Dissection (Level 6) Does not Increase Morbidity After (Total) Thyroidectomy

27.10.2017 | Head and Neck Oncology | Sonderheft 3/2017

In Reply: Prophylactic “First-Step” Central Neck Dissection (Level 6) Does not Increase Morbidity After (Total) Thyroidectomy

24.10.2017 | Head and Neck Oncology | Sonderheft 3/2017

Partial Verification Distorts Estimates of Sensitivity in Diagnostic Accuracy Studies for Fine-Needle Aspiration Cytology

25.10.2017 | Head and Neck Oncology | Sonderheft 3/2017

Reply to: Partial Verification Distorts Estimates of Sensitivity in Diagnostic Accuracy Studies for Fine-Needle Aspiration Cytology

30.10.2017 | Head and Neck Oncology | Sonderheft 3/2017

Factors Influencing the Decision on Surgery or Observation for Patients with Bethesda Category 3 (AUS/FLUS)

20.11.2017 | Head and Neck Oncology | Sonderheft 3/2017

Microsurgical Reconstruction of the Oral Cavity with Free Flaps from the Anterolateral Thigh and Radial Forearm: Example of Confounding by Indication?

30.10.2017 | Head and Neck Oncology | Sonderheft 3/2017

Diffuse Microcalcifications of Only the Thyroid Gland Seen on Ultrasound: Clinical Implication and Diagnostic Approach

09.11.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Yes-Associated Protein (YAP) is a Key Factor for Improving the Management of Cancer Treatments

14.11.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Reply: YAP is a Key Factor to Improve the Management of Cancer Treatments

20.11.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Port-Site Resection in Surgical Management of Incidental Gallbladder Cancer: A Still Unresolved Question

07.11.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply

30.10.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Accurate Evaluation of Tumor Necrosis in the Preoperative Period: A New Challenge

02.11.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Accurate Evaluation of Tumour Necrosis in the Preoperative Period: A New Challenge: In Reply

09.11.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis

09.11.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Reply to: Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis

16.10.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Comments to “Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases”

13.10.2017 | Hepatobiliary Tumors | Sonderheft 3/2017

Comment on “Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases”: A Reply

07.11.2017 | Melanomas | Sonderheft 3/2017

Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases

27.10.2017 | Melanomas | Sonderheft 3/2017

Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases

20.11.2017 | Melanomas | Sonderheft 3/2017

Pre-SN Ultrasound-FNAC can be Sensitive for Lymph Node Metastases in Melanoma Patients if Performed with the Use of the Berlin Criteria

13.11.2017 | Melanomas | Sonderheft 3/2017

Pre-SN Ultrasound-FNAC for Lymph Node Metastases in Melanoma Patients: A Reply

16.10.2017 | Pancreatic Tumors | Sonderheft 3/2017

Analysis of 340 Patients with Solid Pseudopapillary Tumors of the Pancreas: A Closer Look at Patients with Metastatic Disease: Methodological Issues

16.10.2017 | Pancreatic Tumors | Sonderheft 3/2017

Reply to “Analysis of 340 Patients with Solid Pseudopapillary Tumors of the Pancreas: A Closer Look at Patients with Metastatic Disease; Methodologic Issues,” by Safiri, Saeid et al.

01.11.2017 | Pancreatic Tumors | Sonderheft 3/2017

Comment on: MicroRNA Expression as a Predictive Marker for Gemcitabine Response After Surgical Resection of Pancreatic Cancer

27.11.2017 | Thoracic Oncology | Sonderheft 3/2017

Can Vessel Invasion Change the TNM Stage in Non-small Cell Lung Cancer? A Reply

20.11.2017 | Thoracic Oncology | Sonderheft 3/2017

Video-Assisted Thoracic Surgery for Patients with Advanced Stage Non-small Cell Lung Cancer

27.11.2017 | Thoracic Oncology | Sonderheft 3/2017

Video-Assisted Thoracic Surgery for Patients with Advanced-Stage Non-small Cell Lung Cancer: A Reply

20.10.2017 | Thoracic Oncology | Sonderheft 3/2017

Similar Significance of Lymphovascular Invasion with Different Treatment Modalities Among Esophageal Squamous Cell Carcinoma

03.11.2017 | Thoracic Oncology | Sonderheft 3/2017

EGFR Mutation in Patients with Lung Adenosquamous Cell Carcinoma

27.10.2017 | Thoracic Oncology | Sonderheft 3/2017

Reply to “EGFR Mutation in Patients with Lung Adenosquamous Cell Carcinoma”

28.11.2017 | Urologic Oncology | Sonderheft 3/2017

Age and Charlson Score

21.11.2017 | Urologic Oncology | Sonderheft 3/2017

Age and Charlson Score: A Reply

06.11.2017 | Urologic Oncology | Sonderheft 3/2017

Does Red Blood Cell Distribution Width Really Have a Prognostic Role in Upper Tract Urothelial Carcinoma?

13.11.2017 | Urologic Oncology | Sonderheft 3/2017

Comment on: Does Red Blood Cell Distribution Width Really Have a Prognostic Role in Upper Tract Urothelial Carcinoma?

22.01.2016 | Editor Note | Sonderheft 3/2017

Editor Note

20.11.2017 | Correction | Sonderheft 3/2017

Correction to: Reply to ‘‘Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions”

13.12.2016 | Erratum | Sonderheft 3/2017

Erratum to: Trends in Media Reports of Celebrities’ Breast Cancer Treatment Decisions

03.02.2017 | Erratum | Sonderheft 3/2017

Erratum to: E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer

27.03.2017 | Erratum | Sonderheft 3/2017

Erratum to: Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study

11.05.2017 | Erratum | Sonderheft 3/2017

Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group

25.05.2017 | Erratum | Sonderheft 3/2017

Erratum to: Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

17.07.2017 | Erratum | Sonderheft 3/2017

Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer

31.07.2017 | Erratum | Sonderheft 3/2017

Erratum to: Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study

16.08.2017 | Erratum | Sonderheft 3/2017

Erratum to: Predictors of Bowel Function in Long-term Rectal Cancer Survivors with Anastomosis

28.08.2017 | Erratum | Sonderheft 3/2017

Erratum to: Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy

Aktuelle Ausgaben


 

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise